SHFL (Shiftless) is an interferon-stimulated gene that functions as a broad-spectrum antiviral factor through multiple mechanisms 1. Located on chromosome 19.2, SHFL exhibits antiviral activity against diverse RNA and DNA viruses, including flaviviruses (dengue, Zika, West Nile, Japanese encephalitis), HIV-1, hepatitis C virus, SARS-CoV-2, and Kaposi's sarcoma-associated herpesvirus 234. The protein operates through several distinct mechanisms: it directly inhibits -1 programmed ribosomal frameshifting, making it the first human protein with this activity 1; it restricts viral RNA replication by interacting with viral double-stranded RNA intermediates via its zinc finger domain 5; and it disrupts processing body (P-body) formation, affecting RNA fate regulation 6. SHFL is constitutively expressed in hepatocytes and shows remarkable evolutionary conservation between human and mouse orthologs (>95% amino acid identity) 5. The protein's antiviral mechanisms vary by virus type, including negative regulation of viral RNA stability, translation inhibition, and manipulation of RNA granule formation 17. SHFL's diverse antiviral strategies position it as a critical component of innate immunity against viral infections.